221 related articles for article (PubMed ID: 12743560)
1. Identification of cross-reactive and genuine Parietaria judaica pollen allergens.
Stumvoll S; Westritschnig K; Lidholm J; Spitzauer S; Colombo P; Duro G; Kraft D; Geraci D; Valenta R
J Allergy Clin Immunol; 2003 May; 111(5):974-9. PubMed ID: 12743560
[TBL] [Abstract][Full Text] [Related]
2. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of sensitization to Artemisia allergens Art v 1, Art v 3 and Art v 60 kDa. Cross-reactivity among Art v 3 and other relevant lipid-transfer protein allergens.
Lombardero M; García-Sellés FJ; Polo F; Jimeno L; Chamorro MJ; García-Casado G; Sánchez-Monge R; Díaz-Perales A; Salcedo G; Barber D
Clin Exp Allergy; 2004 Sep; 34(9):1415-21. PubMed ID: 15347375
[TBL] [Abstract][Full Text] [Related]
4. Cloning, expression in E. coli and immunological characterization of Par j 3.0201, a Parietaria pollen profilin variant.
Bonura A; Trapani A; Gulino L; Longo V; Valenta R; Asero R; Colombo P
Mol Immunol; 2014 Feb; 57(2):220-5. PubMed ID: 24172226
[TBL] [Abstract][Full Text] [Related]
5. Identification of common allergenic structures in mugwort and ragweed pollen.
Hirschwehr R; Heppner C; Spitzauer S; Sperr WR; Valent P; Berger U; Horak F; Jäger S; Kraft D; Valenta R
J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):196-206. PubMed ID: 9500752
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of Parietaria judaica pollen allergy using natural and recombinant Par j 1 and Par j 2 allergens.
González-Rioja R; Ferrer A; Arilla MC; Ibarrola I; Viguera AR; Andreu C; Martínez A; Asturias JA
Clin Exp Allergy; 2007 Feb; 37(2):243-50. PubMed ID: 17250697
[TBL] [Abstract][Full Text] [Related]
7. The recombinant major allergen of Parietaria judaica and its hypoallergenic variant: in vivo evaluation in a murine model of allergic sensitization.
Orlandi A; Grasso F; Corinti S; Marinaro M; Bonura A; Boirivant M; Colombo P; Di Felice G
Clin Exp Allergy; 2004 Mar; 34(3):470-7. PubMed ID: 15005743
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cross-reactivity between Holoptelea integrifolia and Parietaria judaica.
Sharma S; Panzani RC; Gaur SN; Ariano R; Singh AB
Int Arch Allergy Immunol; 2005 Feb; 136(2):103-12. PubMed ID: 15650307
[TBL] [Abstract][Full Text] [Related]
9. Isolation, expression and immunological characterization of a calcium-binding protein from Parietaria pollen.
Bonura A; Gulino L; Trapani A; Di Felice G; Tinghino R; Amoroso S; Geraci D; Valenta R; Westritschnig K; Scala E; Mari A; Colombo P
Mol Immunol; 2008 May; 45(9):2465-73. PubMed ID: 18289680
[TBL] [Abstract][Full Text] [Related]
10. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.
González-Rioja R; Ibarrola I; Arilla MC; Ferrer A; Mir A; Andreu C; Martínez A; Asturias JA
J Allergy Clin Immunol; 2007 Sep; 120(3):602-9. PubMed ID: 17561242
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactivity between Parietaria species using the major rParj1 and rParj2 allergens.
Bonura A; Artale A; Marino M; Amoroso S; Marcucci F; Geraci D; Colombo P
Allergy Asthma Proc; 2006; 27(5):378-82. PubMed ID: 17063667
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of Parietaria judaica pollen and allergen profiling by an immunoproteomic approach.
Barranca M; Fontana S; Taverna S; Duro G; Zanella-Cleon I; Becchi M; De Leo G; Alessandro R
Biotechnol Lett; 2010 Apr; 32(4):565-70. PubMed ID: 19953298
[TBL] [Abstract][Full Text] [Related]
13. Role of carbohydrate moieties in cross-reactivity between different components of Parietaria judaica pollen extract.
Mucci N; Liberatore P; Federico R; Forlani F; Di Felice G; Afferni C; Tinghino R; De Cesare F; Pini C
Allergy; 1992 Aug; 47(4 Pt 2):424-30. PubMed ID: 1280917
[TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of recombinant Par j 1 and Par j 2 resembling the allergenic epitopes of Parietaria judaica pollen.
Dorofeeva Y; Colombo P; Blanca M; Mari A; Khanferyan R; Valenta R; Focke-Tejkl M
Sci Rep; 2019 Oct; 9(1):15043. PubMed ID: 31636285
[TBL] [Abstract][Full Text] [Related]
15. Plant lipid transfer protein allergens: no cross-reactivity between those from foods and olive and Parietaria pollen.
Tordesillas L; Sirvent S; Díaz-Perales A; Villalba M; Cuesta-Herranz J; Rodríguez R; Salcedo G
Int Arch Allergy Immunol; 2011; 156(3):291-6. PubMed ID: 21720174
[TBL] [Abstract][Full Text] [Related]
16. Detection of pan-allergens in commercial pollen extracts for allergen immunotherapy.
Asero R; Mistrello G; Amato S
Ann Allergy Asthma Immunol; 2016 Aug; 117(2):180-5. PubMed ID: 27238577
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of IgE-binding to Art v 1, Art v 4 and Amb a 1 in mugwort-allergic patients.
Oberhuber C; Ma Y; Wopfner N; Gadermaier G; Dedic A; Niggemann B; Maderegger B; Gruber P; Ferreira F; Scheiner O; Hoffmann-Sommergruber K
Int Arch Allergy Immunol; 2008; 145(2):94-101. PubMed ID: 17823540
[TBL] [Abstract][Full Text] [Related]
18. Tolerance and immunological changes of chemically modified allergen vaccine of Parietaria judaica in accelerated schedules.
Asturias JA; Ferrer A; Arilla MC; Andreu C; Madariaga B; Martínez A
Clin Exp Immunol; 2007 Mar; 147(3):491-6. PubMed ID: 17302898
[TBL] [Abstract][Full Text] [Related]
19. Par j 1 and Par j 2, the major allergens from Parietaria judaica pollen, have similar immunoglobulin E epitopes.
Asturias JA; Gómez-Bayón N; Eseverri JL; Martínez A
Clin Exp Allergy; 2003 Apr; 33(4):518-24. PubMed ID: 12680870
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.
García Villalmanzo I; Hernández MD; Campos A; Giner AM; Polo F; Cortés C; Basomba A
J Investig Allergol Clin Immunol; 1999; 9(5):321-9. PubMed ID: 10582201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
